This study presents the first comprehensive analysis of the prevalence and clinical relevance of clinically actionable CYP2D6 and CYP2C19 alleles, genotypes, and predicted metabolizer phenotypes in a Central Indian population of 509 individuals diagnosed with common mental disorders. This evidence concerns the gene CYP2D6 and psychiatric disorder.